ABCB11 and cholestasis: This inhibition is outside the 10-fold margin between IC50 and Css, avg recommended by the International Transporter Consortium (Kenna et al. 2018), whereas the clinical presentation of the hepatic injury was not consistent with cholestasis, suggesting that the BSEP is likely not driving the hepatotoxicity (Fig. 3C).